ArticleFrontiers in pharmacology2015

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology.

Hugo Geerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.